Global Cell Based Assays Market Insights Forecasts to 2033

• The Global Cell Based Assays Market Size was Valued at USD 17.24 Billion in 2023
• The Market Size is Growing at a CAGR of 7.47% from 2023 to 2033
• The Worldwide Cell-Based Assays Market Size is Expected to Reach USD 35.42 Billion by 2033
• North America is Expected to Grow the fastest during the forecast period.

The Global Cell Based Assays Market Size is Anticipated to Exceed USD 35.42 Billion by 2033, Growing at a CAGR of 7.47% from 2023 to 2033.

Market Overview

Cell-based assays are a method for evaluating the quality and function of a cell product by measuring the reaction in real-time culture. They can be utilized to investigate the regulation of gene, protein, or cell activity and its underlying mechanisms. Cell-based assays can also detect inhibitors that can stimulate biological processes or detect events or effects in the cell. Cell-based assays are considered to be more biologically effective and can aid in the development of novel drugs. They can provide information on the drug efficacy, mechanism of action, safety, off-target effects, and toxicity for a new chemical entity (NCE) in the cellular environment. Also, the assays based on cells can aid in the selection of lead drug candidates. As per the data provided by the U.S. Food and Drug Administration 28 novel drugs or biological products were approved in the first quarter of 2024.

Report Coverage

This research report categorizes the market for the global cell based assay market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global cell based assays market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global cell based assays market.

Driving Factors

The use of cell based assays gives a more practical and informative approach to compare the drug applicants. Rather than relying solely on isolated biochemical reactions, these assays incorporate the complex cellular environment that mimics the conditions similar to the encounter in the human body. This holistic approach identifies the most promising drug candidates early in the development process. These assays also offer an efficient and cost-effective approach to drug discovery. By leveraging multiplexing technologies, researchers can now test numerous compounds simultaneously under diverse conditions, using only small test volumes. This modern approach streamlines the screening procedure which saves precious time, money, and resources whilst evading the want for complicated, multi-step screening methods.

Restraining Factors

The use of high-throughput screening (HTS) and high-content screening (HCS) technologies in cell-based assays has improved their reliability. However, the initial expenditure required to get the appropriate equipment might be major that discourages small research centers and resource-constrained companies from using these technologies. Additionally, each HTS’s duration process and expense are directly correlated with the complexity of the target molecule which results in a more complicated molecule that is expensive too. The usage of these costly tools has increased the overall cost of production significantly in the biopharmaceutical businesses.

Market Segmentation

The global cell based assays market share is classified into type, products & services, and, end-use.

• The drug discovery segment is expected to hold the largest share of the global cell based assays market during the forecast period.   

Based on the type, the global cell based assay market is divided into drug discovery, basic research, and ADME studies. Among these, the drug discovery segment is expected to hold the largest share of the global cell based assays market during the forecast period. The growing importance of drug discovery comes from biotechnology and medicine. The strong growth rate is associated with significant spending by generic companies on research activities, which is expected to boost industry demand in the coming years. Furthermore, the primary research segment is predicted to grow across the dimensions due to the application of cell-based assays in many chronic diseases in developing countries. Further research should be carried out in cardiovascular and in more arthritis, which will help expand the market.

• The assay kits segment is expected to grow at the fastest CAGR in the global cell based assays market during the forecast period.   

Based on the products & services, the global cell based assays market is divided into reagents, assay kits, microplates, and probes & labels. Among these, the assay kits segment is expected to grow at the fastest CAGR in the global cell based assays market during the forecast period. This segment is predicted to grow rapidly due to its efficiency in various applications in biopharmaceutical applications. These kits are important for many aspects of cellular function such as cell cycle progression, motility, and invasion, as well as important cellular processes for measuring cell viability. In addition, it is used to determine the quantities of essential cell components used to measure cell viability and response to diverse stimuli.

• The pharmaceuticals & biopharmaceutical companies segment is expected to grow at the fastest CAGR in the global cell based assays market during the forecast period.   

Based on the end-use, the global cell based assays market is divided into academic & government research institutes, pharmaceuticals & biopharmaceutical companies, and contact research organizations. Among these, the pharmaceuticals & biopharmaceutical companies are expected to grow at the fastest CAGR in the global cell based assays market during the forecast period. The growing popularity of the cell-based assay in numerous biotech and pharmaceutical companies because of its benefits. The expanded requirement to ensure that cells are correctly proliferated and measured for toxicity and motility is expected to boost revenue growth in the course of the time frame predicted.

Regional Segment Analysis of the Global Cell Based Assays Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

Asia Pacific is anticipated to hold the largest share of the global cell based assays market over the predicted timeframe.

Asia Pacific is anticipated to hold the largest share of the global cell based assays market over the predicted timeframe. The region's cell-based assay market is also expected to be driven by the bolstering of biopharmaceutical investment, increased R&D investment, public-private partnerships for life sciences research, and pharmaceuticals on increasing discovery and development research. A growing aging population, expansion in the healthcare industry, and availability of major research and development initiatives will drive the market growth.

North America is expected to grow at the fastest pace in the global cell based assays market during the forecast period. The region has been credited to the united efforts of university research institutes and pharmaceutical companies, which have undertaken considerable research in several research institutes around the region. Furthermore, the area's thriving biopharmaceutical and biotechnology sector and the rising emphasis on custom-designed treatment are riding marketplace growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global cell based assays market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Danaher Corporation
• Becton, Dickinson and Company
• Perkinelmer, Inc.
• Cell Signaling Technology, Inc.
• Thermo Fisher Scientific Inc.
• Charles River Laboratories International, Inc.
• DiscoverX Corporation
• Biognosys
• F. Hoffmann-La Roche AG
• Eurofins DiscoverX Products
• Macrogen Inc
• Bio-Rad Laboratories, Inc.
• Lonza Group AG
• Promega Corporation
• Merck KGA
• Beckman Coulter, Inc.
• Corning Inc.
• AAT Bioquest, Inc.
• Lebermuth, Inc.
• GE Healthcare
• Menarini Silicon Biosystems, Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In September 2023, Agilent and ACTRIS collaborated to accelerate cell and gene therapy in Singapore.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global cell based assays market based on the below-mentioned segments: 

Global Cell Based Assays Market, By Type

• Drug Discovery
• Basic Research
• ADME Studies

Global Cell Based Assays Market, By Products & Services

• Reagents
• Assay Kits
• Microplates
• Probes & Labels

Global Cell Based Assays Market, By End-Use

• Academic & Government Research Institutes
• Pharmaceuticals & Biopharmaceutical Companies
• Contact Research Organizations

Global Cell Based Assays Market, Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa